Rathmell: To improve funding outlook, we must reverse distrust in science

OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill

The Trump administration has a fight on its hands as it pushes forward with a plan to exert greater political control over government funding of science.

Ned Sharpless’s portrait unveiled at FNIH ceremony

Former NCI director Norman “Ned” Sharpless had his portrait unveiled at a ceremony hosted by the Foundation for the National Institutes of Health on the main NIH campus in Bethesda.

July 10, 2026

Vol.52 No.27

In Brief

ARPA-H awards up to $160M to advance personalized curative medicines for rare genetic diseases

The Advanced Research Projects Agency for Health, an agency within the U.S. Department of Health and Human Services, announced the teams for the Treating Hereditary Rare Diseases with In Vivo Precision Genetic Medicines (THRIVE) program—a critical investment toward bringing new treatments to patients faster and curing rare genetic pediatric diseases.

July 10, 2026

Vol.52 No.27

In Brief

Cancer Research Institute issues 93 awards totaling $37 million

The Cancer Research Institute announced its largest-ever annual grantmaking—93 awards totaling $37 million—as federal funding for cancer research remains uncertain.

July 10, 2026

Vol.52 No.27

Cancer Policy

AACR urges OMB to retract proposed rule on federally funded research

The American Association for Cancer Research is urging the White House Office of Management and Budget to rescind its recent proposed rule that would give the administration unprecedented political control over government-funded science.

July 02, 2026

Vol.52 No.26

By Sara Willa Ernst

Podcast The Directors

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.

June 26, 2026

Vol.52 No.25

By Paul Goldberg and Claire Marie Porter

Rathmell: To improve funding outlook, we must reverse distrust in science

YOU MAY BE INTERESTED IN

OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill

Ned Sharpless’s portrait unveiled at FNIH ceremony

ARPA-H awards up to $160M to advance personalized curative medicines for rare genetic diseases

Cancer Research Institute issues 93 awards totaling $37 million

AACR urges OMB to retract proposed rule on federally funded research

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

Renew today!

Subscriber content

Never miss an issue!

Login

Rathmell: To improve funding outlook, we must reverse distrust in science

YOU MAY BE INTERESTED IN

OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill

Ned Sharpless’s portrait unveiled at FNIH ceremony

ARPA-H awards up to $160M to advance personalized curative medicines for rare genetic diseases

Cancer Research Institute issues 93 awards totaling $37 million

AACR urges OMB to retract proposed rule on federally funded research

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas“Institutions are feeling crunched in so many different directions”

Never miss an issue!

Login

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”